 The aim of this study is to compare predecidualization and endometrial receptivity as gene expression by using subcutaneous progesterone 25 mgday versus intramuscular progesterone 50 mgday in healthy women of childbearing age. Both, the two drugs and the doses administered in this clinical trial, are routine clinical practice. 